Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 20Terminated 3Unknown 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 3

Conditions

Neoplasms 3Breast Neoplasms 2Stress Disorders, Post-Traumatic 1Sedentary Behavior 1Pulmonary Disease, Chronic Obstructive 1Prostate Adenocarcinoma 1Pain 1Overweight 1Obesity 1Motor Activity 1Melanoma 1Lung Neoplasms 1Leukemia 1Digestive System Neoplasms 1Depression 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Arthralgia 1Anxiety Disorders 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Gemcitabine 34pembrolizumab 26Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Educational Status × Clear all
NCT05477784 2026-01-21

EC-PC

University of Washington

Phase NA Terminated
174 enrolled
Tumor-Agnostic

Neoplasms

NCT04278534 2023-08-30

Virtual Reality for the Education of Cancer Patients Undergoing Radiation Therapy

OHSU Knight Cancer Institute

Phase NA Terminated
27 enrolled
Tumor-Agnostic

Neoplasms

NCT02440737 2019-10-18

NEST

Vanderbilt-Ingram Cancer Center

Phase NA Terminated
67 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡